Pomerantz Investigates Organogenesis Holdings Securities Fraud Claims.

Pomerantz LLP is investigating claims of securities fraud against Organogenesis Holdings Inc. (NASDAQ: ORGO) on behalf of investors. The investigation concerns the withdrawal of final Local Coverage Determinations related to skin substitute grafts/cellular and tissue-based products, which increased competition for the company. As a result, Organogenesis' stock price fell 10.14% to close at $5.28 per share. Investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980, to learn more about joining the class action.